Spinoffs & Takeovers Hotline – Friday, June 2, 2023

TECNOGLASS INC., $40.75, symbol TGLS on New York, is a leading producer of architectural glass, windows, and associated aluminum products serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass transformation company… Read More

Consumer-focused ETFs add stability

Consumer companies such as Walmart, Kellogg and Nestle provide basic goods that consumers need, even during a recession. It is therefore not surprising that these companies have relatively consistent revenue and profit histories and are able to maintain their dividends even during tough economic times.
These… Read More

Consumer staples offer strength in downturns

Traditionally, the price of most stocks, and the ETFs that hold them, drop during market declines. However, certain segments generally perform better than the overall market. Below, we highlight three ETFs focused on firms that produce and sell consumer staples. They should, as in past… Read More

European ETFs offer long-term promise

European stocks continue to face near-term challenges as the war in Ukraine, record inflation and the continuing impact of the COVID-19 pandemic weigh on their prospects. Still, the long-term outlook for top European companies is strong, and many of these leading companies derive a significant… Read More

This global food giant is a top Swiss stock

Nestle is the largest holding in the iShares MSCI Switzerland ETF at 21.5%. That’s high for any single stock, but the firm continues to be a top global stock.
As a 150-year-old company, Nestle is the largest food producer and distributor in the world. Its size… Read More

Switzerland is rebounding from COVID

Switzerland has a stable, export-oriented economy, which regularly ranks among the world’s most competitive. In addition, it is home to some of the top performing and best-known global companies. COVID-19 slowed the economy along with most other nations—and it’s still a risk. But the outlook… Read More